Heterozygous deletions in CFHR3-CFHR1 genes have also been linked to atypical hemolytic uremic syndrome in pediatric ALL patients and transplant-associated thrombotic microangiopathy in neuroblastoma patients [50,51]. Here, CFHR1 is linked to atypical hemolytic-uremic syndrome.